News

​Gene causing sickle cell disease removed by scientists Study opens door to similar gene-cutting strategies to cure a range of genetic diseases Thu, Jun 24, 2021, 06:00 Seán Duke Dr Ciaran Lee is based at APC Microbiome Ireland SFI Research Centre in University College Cork. Photograph: Tomas Tyner Scientists have used a DNA cutting technique to...

​French biopharma company Ipsen invests €25m Dublin plant Investment aimed at boosting capacity of plant to produce ‘transformative medicine’ Staff at Ipsen’s Dublin site work in research and development, manufacturing and also on the commercial side of the business. French biopharma company Ipsen is investing €25 million to boost manufacturing ...

Using platelets as little health sensors in our blood Research Lives: Patricia Maguire, Professor of Biomedical Science at University College Dublin Proft Patricia Maguire receiving the NovaUCD Invention of the year award 2021 on behalf of the team for AI_PREMie. Photograph: Nick Bradshaw Your research is on blood platelets, what do you find int...

​Irish scientists make discovery on dangerous Covid clotting Work could help in developing treatments to prevent life-threatening complication Irish scientists have identified how some Covid-19 patients can develop life-threatening clots, which could lead to targeted therapies to prevent it from happening. The balance between a molecule that cau...

​Irish pharma company APC invests €25m in vaccine manufacture Investment will see the creation of 120 jobs at ‘medicines accelerator’ Thu, Jun 10, 2021, 10:00 Updated: Thu, Jun 10, 2021, 10:19 Dominic Coyle Process development engineer Becca Dunne at APC, the pharmaceutical research and development company that announced a €25 million investment...

Employees want flexibility in where and when they work, EY survey finds Updated / Monday, 14 Jun 2021 15:06 The data shows that nine in ten employees now want flexibility in where and when they work Over half of employees would consider leaving their job post pandemic if they are not given some form of flexibility in where and when they work, ac...

US approves Biogen Alzheimer's drug Biogen said it has priced the drug, to be sold as Aduhelm, at $56,000 per year US regulators have approved Biogen's aducanumab as the first treatment to attack a likely cause of Alzheimer's disease, sending its shares soaring, despite controversy over whether the clinical evidence proves the drug works. Biogen...

Shannon med-tech firm heads up €5.4m orthopaedic project The project, called OsStic, is aiming to develop a bioinspired adhesive that will stick broken bone tissue together. Staff at Shannon-based medical technology firm PBC BioMed which designs, develops, and manufactures medical devices. TUE, 01 JUN, 2021 - 22:07 ALAN HEALY Shannon-based medic...

Thousands who lost jobs to get free training in digital skills under recovery plan Retrofitting homes to be focus of re-training and new bid to tackle student digital divide Minister for Further and Higher Simon Harris said Covid-19 has accelerated us towards a “digitally dominated economy”. Photograph: Brian Lawless/PA Wire Separately, Minister...